Results of the TCR-β and TCR-γ rearrangement analysis
| . | n . | TCR-β . | TCR-γ . |
|---|---|---|---|
| T-cell lymphomas | 62 | 61/62 (98%) | 50/62 (80%) |
| Controls | |||
| B-cell lymphomas | 15 | 0/15 (0%) | 0/15 (0%) |
| Lymphadenopathies | 11 | 0/11 (0%) | 0/11 (0%) |
| PBMCs | 10 | 0/10 (0%) | 0/10 (0%) |
| Psoriasis vulgaris | 12 | 0/12 (0%) | 0/12 (0%) |
| Dermatitis, unspecific | 4 | ||
| T-cell lines | 8 | 8/8 (100%) | 8/8 (100%) |
| TCL* | 18 | 18/18 (100%) | 18/18 (100%) |
| . | n . | TCR-β . | TCR-γ . |
|---|---|---|---|
| T-cell lymphomas | 62 | 61/62 (98%) | 50/62 (80%) |
| Controls | |||
| B-cell lymphomas | 15 | 0/15 (0%) | 0/15 (0%) |
| Lymphadenopathies | 11 | 0/11 (0%) | 0/11 (0%) |
| PBMCs | 10 | 0/10 (0%) | 0/10 (0%) |
| Psoriasis vulgaris | 12 | 0/12 (0%) | 0/12 (0%) |
| Dermatitis, unspecific | 4 | ||
| T-cell lines | 8 | 8/8 (100%) | 8/8 (100%) |
| TCL* | 18 | 18/18 (100%) | 18/18 (100%) |
TCR: T-cell receptor; PBMCs: Peripheral blood mononuclear cells of healthy donors.
TCL: T-cell lymphomas with known and sequenced clonal TCR-γ rearrangements.